On 7 March 2021 began the 14th UN Congress on Crime Prevention and Criminal Justice in Kyoto, Japan, with the aim of renewing global cooperation against crime to achieve the Sustainable Development Goals and recover from the pandemic. The Kyoto Declaration was adopted during the event where governments agreed to Read more…
The latest ‘Medical Product Quality Report – COVID-19 Issues’ from Medicine Quality Research Group, Centre of Tropical Medicine & Global Health, Nuffield Department of Medicine and the University of Oxford from December 2020 highlights the rise of substandard and falsified medicines linked to COVID-19. Throughout 2020 the MQM Globe database tracked and identified over Read more…
The AHAIC 2021 conference will take place from 8th to 10th March this year, hosted by Amref Health Africa. This African-led global convening is expected to attract over 1,800 delegates from over 40 countries, to discuss systems and innovations needed to enable Africa to achieve Universal Health Coverage. With a virtual Read more…
PRESS RELEASE Patients, product development partnerships and private health sector representatives call for the rapid ratification of the African Medicines Agency Treaty to speed up timelines to vaccines and medicines approval London / Geneva, 5 February 2021 – On the eve of the 34th African Union Summit, two years after Read more…
This is a statement made at the 148th session of the WHO Executive Board on Agenda item 10: Substandard and falsified medical products by members of the Fight the Fakes Alliance. On behalf of the World Heart Federation, International Alliance of Patient Organizations, International Council of Nurses, International Federation of Pharmaceutical Manufacturers Read more…
New Curriculum Guide and Competency Framework A curriculum guide to support educators in ensuring that pharmacists are better able to prevent substandard or falsified (SF) medicines and medical products from reaching patients has been published by the International Pharmaceutical Federation (FIP) in partnership with the World Health Organization (WHO). In Read more…
More and more reports of falsified COVID-19 vaccines are being reported around the world. With COVID-19 vaccines being approved for use in different parts of the globe, the scale and complexity of their manufacture, allocation and distribution globally will be unprecedented. This will also present corruption risks that may Read more…
UNODC publishes policy paper on substandard and falsified COVID-19 Vaccine risks. With COVID-19 vaccines being approved for use in different parts of the globe, the scale and complexity of their manufacture, allocation and distribution globally will be unprecedented. This also present’s corruption risks that may threaten vital public health goals. Read more…
Adam Aspinall, Chair of the Fight the Fakes Alliance and Senior Director of Access and product management at Medicines for Malaria Venture (MMV) explained the importance of the Alliance’s work as reports of substandard and falsified medicines continue to increase. As counterfeiters become increasingly tech savvy, more and more unsuspecting Read more…
On 7 December 2020, we officially launched the Fight the Fakes Alliance. With 16 member organisations representing the biopharmaceutical industry, pharmacists, wholesalers, researcher and patients, the Alliance is uniquely positioned to holistically address the rising burden of substandard and falsified medicines. Read more about the launch of the Alliance in Read more…